Decoy Therapeutics (DCOY) EBIT Margin (2016 - 2026)
Decoy Therapeutics (DCOY) recorded EBIT Margin of -1155.84% in Q2 2026.
Powered by 
Analysis
Decoy Therapeutics (DCOY) EBIT Margin (2016 - 2026) Analysis & Trends
On a TTM basis, Decoy Therapeutics' EBIT Margin came in at -6521.34% as of Jun 30, 2026; for FY2021, it was -696.27%, down 547.49 percentage points from FY2020.
- Annual EBIT Margin has a five-year change of +3250.27 percentage points (FY2016 to FY2021).
- Across earlier years, EBIT Margin came in at -148.78% in FY2020 (+89.74 pp), -238.53% in FY2019 (-152.20 pp), -86.33% in FY2018 (+2638.32 pp) and -2724.65% in FY2017 (+1221.89 pp).
- The Q2 2026 figure is the highest quarterly EBIT Margin since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Decoy Therapeutics | 571,865.63 | -31.06 Mn | - | -1,155.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,155.84% |
| Mar 31, 2026 | -3,863.48% |
| Dec 31, 2025 | -15,876.01% |
| Sep 30, 2025 | -4,132.07% |
| Mar 31, 2025 | -18,758.95% |
| Dec 31, 2024 | -6,007.72% |
| Sep 30, 2024 | -2,930.05% |
| Jun 30, 2024 | -3,406.18% |
| Mar 31, 2024 | -3,145.34% |
| Dec 31, 2023 | -1,091.84% |
| Sep 30, 2023 | -2,833.40% |
| Jun 30, 2023 | -4,220.98% |
| Jun 30, 2021 | -545.48% |
| Mar 31, 2021 | -142.23% |
| Dec 31, 2020 | -118.82% |
| Sep 30, 2020 | -127.59% |
| Jun 30, 2020 | -152.89% |
| Mar 31, 2020 | -209.17% |
| Dec 31, 2019 | -198.33% |
| Sep 30, 2019 | -429.76% |
API Access
Decoy Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=DCOY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "DCOY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=DCOY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();